. 2008 Apr;65(Suppl 1):54–59. doi: 10.1111/j.1365-2125.2008.03136.x

Table 3.

Summary of statistical analysis of maraviroc pharmacokinetics parameters

	AUC₁₂ (ng h ml⁻¹)^*	C_max (ng ml⁻¹)^*	T_max (h)^†
*Maraviroc + efavirenz/lamivudine/ zidovudine vs.* maraviroc alone**	46.9 (30.3, 72.4)	66.5 (40.8, 109)	−0.75 (−1.44, −0.06)
*Maraviroc + efavirenz/didanosine/ tenofovir vs.* maraviroc alone**	48.3 (31.3, 74.6)	76.4 (46.8, 125)	−1.00 (−1.69, −0.31)
*Maraviroc + nevirapine/lamivudine/ tenofovir vs.* maraviroc alone**	101 (65.1, 155)	154 (94.3, 251)	−0.88 (−1.57, −0.18)
*Maraviroc + lopinavir/ritonavir/stavudine/ lamivudine vs.* maraviroc alone**	265 (161, 435)	180 (103, 314)	0.68 (−1.47, 0.12)

Ratio of geometric means (90% CI), log-transformed parameters.

^†

Difference between means (90% CI), untransformed parameters.